Bristol-Myers gets $1.6 billion offer for French consumer health unit

Go back to Bristol-Myers gets $1.6 billion offer for French consumer health unit

Bristol-Myers Squibb (BMY) Reports Offer from Taisho Pharmaceutical Holdings Co., Ltd to Purchase UPSA Consumer Health Business for $1.6B

December 19, 2018 5:48 AM EST

Bristol-Myers Squibb Company (NYSE: BMY) today announced that Taisho Pharmaceutical Holdings Co., Ltd. (Taisho) has offered to purchase Bristol-Myers Squibbs UPSA consumer health business for $1.6 billion. UPSA develops and delivers important consumer medicines for patients in France, across Europe and additional countries. Taisho is the largest over-the-counter (OTC) drug company... More